AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Boston ,Massachusetts ,United States ,Germany ,Deerfield ,Henry Skinner ,Greg Merril ,Martin Heidecker ,Bill Burns ,Eli Lilly ,Chris Burns ,Glaxosmithkline ,Amgen ,Us Centers For Disease ,Action Fund ,Boehringer Ingelheim ,Deerfield Management Company ,Novartis ,Pfizer ,International Federation Of Pharmaceutical Manufacturers ,Merck Kga ,International Federation Of Pharmaceutical Manufacturers Associations ,European Commission Under Horizon ,European Union ,Wellcome ,Novo Nordisk Foundation ,European Investment Bank ,World Health Organization ,Boehringer Ingelheim Foundation ,Venatorx Pharmaceuticals ,Merck Kgaa ,Johnson ,Lundbeck ,Novo Nordisk ,Adaptive Phage Therapeutics ,Disease Control ,Board Chair ,International Federation ,Pharmaceutical Manufacturers ,Wellcome Trust ,Phage Therapeutics ,Deerfield Management ,Abingworth Management ,Venatorx Pharmaceutical President ,Chief Investment Officer ,Adaptive Phage ,European Commission ,Health ,Business ,Pr Newswire ,